| D-0055-2025 | Class II | Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually | October 31, 2024 |
| D-0471-2023 | Class II | Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for | March 10, 2023 |
| D-0472-2023 | Class II | Daytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for | March 10, 2023 |
| D-0473-2023 | Class II | Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for | March 10, 2023 |
| D-0470-2023 | Class II | Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for | March 10, 2023 |
| D-0071-2023 | Class II | Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches | November 16, 2022 |
| D-1169-2022 | Class II | Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 P | June 24, 2022 |
| D-0889-2022 | Class II | Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 P | May 6, 2022 |
| D-0724-2021 | Class II | Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice W | July 30, 2021 |
| D-0725-2021 | Class II | Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice We | July 30, 2021 |
| D-0394-2021 | Class II | Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), 30 Patches ( | May 20, 2021 |
| D-0393-2021 | Class II | Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches ( | May 20, 2021 |
| D-0336-2021 | Class II | Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by: Nov | April 16, 2021 |
| D-0337-2021 | Class II | Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven Pharmace | April 16, 2021 |
| D-0296-2021 | Class II | Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) Contains: 30 P | February 19, 2021 |
| D-0294-2021 | Class II | Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), Contains: 30 | February 19, 2021 |
| D-0293-2021 | Class II | Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), Contains: 30 | February 19, 2021 |
| D-0295-2021 | Class II | Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) Contains: 30 P | February 19, 2021 |
| D-1210-2018 | Class II | Minivelle (estradiol transdermal system) Patches, Delivers 0.075 mg/day, 8 count boxes, Rx only, Mfd | September 7, 2018 |
| D-1208-2018 | Class II | Minivelle (estradiol transdermal system) Patches, Delivers 0.05 mg/day, a) 2 count and 8 count boxes | September 7, 2018 |